The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Clinical trial NCT03879863 · COMPLETED
Trial details
- NCT number
- NCT03879863
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2019-10-04
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.